Tallal M. Hashmi, MD

Stroke I Neurology I Endovascular Surgery

[Ameer E. Hassan @AmeerEHassan]

We've got exciting news, https://t.co/rquPLtU9Nr is officially part of the 2026 @MedTechInnovator accelerator! Many thanks to the mentors, investors, and reviewers who believe in our vision. We can't wait to get started!

#MTI2026Cohort #MedTechInnovator #MedicalDeviceInnovation #Medtech #FutureOfHealth #Startups

@_AdnanSiddiqui @qureshiai @JacobsInstitute @svinsociety @MThrombectomy #WeberUltrasonics @Hydrix_Australia

https://t.co/32lA1FxDpD

https://t.co/JNYanTT4Ex

[Gregg Fonarow MD @gcfmd]

In-Hospital Stroke Quality and Outcomes in the Mechanical Thrombectomy Era: Get With The Guidelines-Stroke, 2016 to 2023 | Stroke https://t.co/gSqb99XMMj

@American_Stroke @StrokeAHA_ASA @AHAScience @AHA_Research #GWTG @brianmacgrory @ShumeiManMD

[Mushood Ahmed @MushoodCh]

Our meta-analysis now published in @ESC_Journals

#GLP1Agonists #MedTwitter #Diabetes #CardiovascularDisease #MetaAnalysis

[NEJM @NEJM]

Among patients with stroke due to medium-vessel occlusion, thrombectomy led to functional independence at 90 days (in 58.6% of patients, vs. 46.6% with medical management) but also to a higher risk of intracranial hemorrhage. Full ORIENTAL-MeVO trial results: https://t.co/FvyLPQz4CV

Editorial: Endovascular Therapy for Medium-Vessel Occlusion Stroke — Narrowing the Target Population https://t.co/hnLi0DvzuF

[Umberto Pensato @UPensato]

Redefining the Cerebral Ischemic Core-Penumbra-Oligemia Continuum @StrokeAHA_ASA @johanna_ospel @draravindganesh @nishita_singh3 @AlmekhlafiMa @BroocksGabriel @Libero131087 @DGutierrez__V @NguyenThanhMD @VYogendrakumar @ZiniAndrea @KimBJstroke https://t.co/QmPTYNtaPt

[Stroke AHA/ASA @StrokeAHA_ASA]

Faster Thrombolysis, Sharper Minds: Early Alteplase or Tenecteplase Linked to Better Poststroke Cognition

In this #BloggingStroke post, Anel Karisik discusses #Stroke article by Sujanthan et al. https://t.co/VRnsNUJy6L

[SCCM Neuroscience Section @SCCM_Neuro]

Intensive BP control following MT does not improve functional outcomes & may be associated w/ harm, including ⬇️rates of good functional outcome, ⬆️all‐cause mortality, & ⬆️incidence of hypotensive episodes.🧠

https://t.co/pjA1PXgNjy

#SCCMNeuro #NeuroICU #NeuroX #NeuroTwitter

[Tallal M. Hashmi, MD @hashmit338]

@JAHA_AHA @StrokeAHA_ASA

[Tallal M. Hashmi, MD @hashmit338]

I am pleased to share our recent publication in the Journal of the American Heart Association (JAHA).

Our findings further support the 2026 American Heart Association/American Stroke Association guidelines, demonstrating that intensive blood pressure reduction following endovascular thrombectomy is associated with less favorable clinical outcomes.

I am sincerely grateful to all collaborators and colleagues whose contributions made this work possible.

@AmeerEHassan @gcfmd @MushoodCh @ShakirMbbs @RaheelA29288418

[Tallal M. Hashmi, MD @hashmit338]

https://t.co/xf1u6LcvRw

[JNIS @JNIS_BMJ]

🧠⚡️ Systematic review of 532 LVO patients shows super large bore aspiration catheters achieve high access (92%) and strong reperfusion (81%) with low complications, but modest first-pass effect (~55%) and reliance on non-randomized data highlight the need for larger prospective trials. Read more here: https://t.co/b6gHNIY6qN
@MagJablonska @marcriboj

[Stephan A Mayer @stephanamayer]

Lowering BP excessively (SBP <140) after thrombectomy worsens outcome.

This effect is even more pronounced when ischemic leukopathy is present, likely due to impaired autoregulation.

https://t.co/wxBqAWJHUK

[Muhammad Qudrat Ullah, MD @QudratUllahRana]

🚨 The 2026 AHA/ACC PE guidelines changed how we think about pulmonary embolism.
Not just new treatments — a new clinical framework.
Say goodbye to “massive vs submassive.”
Meet A–E PE Clinical Categories 🧵👇

[Malik Ghannam @GhannamMalik]

Outcomes of Endovascular Treatment for Acute Basilar Artery Occlusion With National Institutes of Health Stroke Scale Score ≤10 | Journal of the American Heart Association https://t.co/EnodwRru0U

[Mushood Ahmed @MushoodCh]

Our new meta-analysis in @ESC_Journals! 🫀

High-certainty evidence supporting IV FCM therapy in #HeartFailure.
📖 Read: https://t.co/CX0bHbgHdG

#Cardiology #IronDeficiency #CardioTwitter

@JamalRanaMD @SJGreene_md @FudimMarat @robmentz @gcfmd

[Gregg Fonarow MD @gcfmd]

Association of Component Strategies of the Target Stroke Phase 3 Nationwide Quality Improvement Program With Accelerated Door-to-Puncture and Door-In-Door-Out Times for Ischemic Stroke Endovascular Thrombectomy in the United States https://t.co/Lfdt5Onvjv

@AHAScience @DCRINews

[Mushood Ahmed @MushoodCh]

New publication in @AHJPlus
📊 Meta-analysis (16 RCTs, n=20,601)
🩺 Colchicine ↓ MI risk
⚖️ No effect on all-cause/CV death
⚠️ ↑ GI AEs & discontinuations
🔗 https://t.co/wJUlzFo98Q

@JamalRanaMD @FudimMarat @gcfmd

[Tallal M. Hashmi, MD @hashmit338]

https://t.co/rdkdoF7BL6

[Tallal M. Hashmi, MD @hashmit338]

Intravenous thrombolysis prior to mechanical thrombectomy demonstrated comparable outcomes to thrombectomy alone in terms of functional recovery, recanalization, mortality, and hemorrhage.

@AmeerEHassan
@gcfmd
@RaheelA29288418
@MushoodCh
@ShakirMbbs

[Ameer E. Hassan @AmeerEHassan]

Thank you @NN_publishing NeuroNews for highlighting our work at Quantanosis, pioneering a new era in stroke treatment without wires or lytics. We're committed to democratizing access and improving outcomes with focused innovation 😉 #Stroke #NeuroInnovation @svinsociety @MThrombectomy @MokinMax @SuspectedLVO @SunilAShethMD @almuftifawaz @CerebrovascLab @_AdnanSiddiqui @NguyenThanhMD @YoungNIR @uclahealthmsu @AlexandraCzap @wondeasa @WorldStrokeEd